Gulden introduces compact color blindness diagnostic tools

Article

Gulden Ophthalmics now offers 2 new magnetic D-15 color blindness diagnostic kits. The test can help determine between congenital or acquired, moderate and strong defects in deutan, protan, or tritan color discrimination.

Elkins Park, PA-Gulden Ophthalmics offers two new compact magnetic D-15 color blindness diagnostic kits. The kits are comprised of numbered colored discs housed in a compact sealed plastic box that is only 16 x 4 inches, saving counter space in the examination room. 

The tests are easy to administer as well as simple and easy to perform by patients. Patients simply use a magnetic stylus to arrange the discs in the correct color order as they perceive it, and the arrangement is evaluated. Patients with color perception deficiencies will have difficulties trying to arrange the colored discs and will usually make mistakes. Based on the patient’s arrangement, the test can help determine between congenital or acquired moderate, and strong defects in deutan, protan, or tritan color discrimination. Based on the mistakes the type of color blindness as well its severity can be calculated. The tests can be used for occupational evaluation and classification.

Encased in the plastic enclosure, the discs are kept clean (not subject to fingerprints as in unenclosed, unprotected test kits), and cannot be lost; a Velcro cover protects the discs from fading due to sunlight and ambient light. The kits include a magnetic stylus with leather pouch and score sheet.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.